1. Canada Stocks

  2. •

    Consumer Cyclical

  3. •

    Packaging & Containers
Winpak Ltd.

Winpak Ltd.

WIPKF
Winpak Ltd.US flagOther OTC
32.15
USD
-0.44
- -
1.89BMarket Cap
Winpak Ltd.
WIPKF
(Other OTC)

Recent

price

32.15

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
8.91
10.03
10.31
11
12.1
12.26
12.65
13.64
13.69
13.44
13.12
15.42
18.17
17.56
17.78
18.44
14.5
Revenue per Share
0.81
0.98
1.1
1.1
1.21
1.53
1.61
1.84
1.68
1.77
1.64
1.6
1.97
2.28
2.35
2.25
1.7
Basic EPS, GAAP
0.57
0.71
0.23
0.55
0.75
1.57
0.82
1.33
0.9
1.57
1.61
0.75
0.43
2.34
0.91
1.65
0.78
Free Cash Flow per Basic Share
0.12
0.12
0.12
0.12
1.01
1.23
0.09
0.09
0.09
0.09
0.09
2.55
0.09
0.09
0.1
2.29
0.11
Dividend per Share
6.58
6.74
7.7
8.87
8.99
9.3
10.86
12.59
14.16
15.92
17.44
16.61
18.5
20.77
20.09
21.64
22.93
Book Value per Share
6.25
6.5
7.47
8.64
8.76
9.07
10.63
12.37
13.94
15.35
16.89
16.08
17.99
20.28
19.61
21.15
22.44
Tangible Book Value per Share
65
65
65
65
65
65
65
65
65
65
65
65
65
65
64
61
59
Basic Weighted Avg Shares
579
652
670
715
787
797
823
887
890
874
852
1,002
1,181
1,141
1,131
1,125
859
Sales/Revenue/Turnover
13.62
14.69
15.23
15.17
15.28
18.87
19.56
18.21
17.09
17.84
17.24
14.09
15.18
15.72
17.03
15.58
20.54
Operating Margin (%)
28
29
27
28
32
33
36
39
42
45
46
47
49
50
55
57
43
Depreciation Expense
53
64
71
71
78
99
104
119
109
115
106
104
128
148
149
137
101
Net Income, GAAP
31.36
32.08
30.31
30.95
30.85
30.88
31.52
24.04
26.37
26.11
26.27
24.9
26.34
26.13
28.04
26.89
27.15
Effective Tax Rate (%)
9.07
9.78
10.63
9.99
9.96
12.45
12.69
13.45
12.24
13.13
12.47
10.36
10.87
12.98
13.22
12.2
11.73
Profit Margin (%)
199
226
250
292
293
294
365
465
539
602
713
661
775
890
718
727
786
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
13
12
11
12
16
14
- -
LT Debt
444
454
516
593
601
623
727
843
948
1,066
1,167
1,116
1,239
1,384
1,284
1,323
1,381
Total Equity
12.95
14.44
14.55
13.44
13.91
16.82
16.12
15.56
12.47
11.39
9.62
9.18
11.02
9.94
10.25
9.7
9.51
Return on Invested Capital (%)
12.21
14.52
14.71
12.84
12.95
15.81
14.91
14.8
11.9
11.08
9.26
8.82
10.84
11.27
11
10.47
7.49
Return on Capital (%)
13.11
14.73
15.19
13.26
13.5
16.7
15.93
15.66
12.53
11.74
9.81
9.38
11.25
11.61
11.5
10.83
7.64
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
3
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
14
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
60
59
59
Market Capitalization
1,940
1,880
1,777

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
864
857
892
Cash, Cash Equivalents & STI
376
353
342
Accounts Receivable, Net
200
237
269
Inventories
252
248
263
Total Current Liabilities
136
98
107
Payables & Accruals
64
97
104
ST Debt
3
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.11%
2.83%
3.03%
Free Cash Flow
41.48%
71.12%
72.87%
Net Income, GAAP
3.83%
5.9%
-8.1%
Sales/Revenue/Turnover
3.78%
6.13%
-0.48%
Total Cash Common Dividend
460.26%
939.37%
2,011.42%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
277
283
285
285
1,131
2025
285
273
- -
285
1,125
2026
280
294
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.55
0.61
0.61
0.58
2.35
2025
0.56
0.49
- -
0.6
2.25
2026
0.53
0.57
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.02
0.02
0.04
0.1
2025
2.16
0.04
- -
0.04
2.29
2026
0.04
0.04
- -
- -
- -
Similar Companies
DSS, Inc. (DSS)
ShenZhen YUTO Packaging Technology Co., Ltd. (002831.SZ)
Stora Enso Oyj (SEOJF)
SCG Packaging Public Company Limited (5Y7.F)
Hexagon Composites ASA (HEX.OL)
SCG Packaging Public Company Limited (5Y7A.F)
Business
Winpak Ltd. manufactures and distributes high-quality flexible and rigid packaging materials along with related packaging machines primarily for perishable foods, beverages and healthcare applications; its product portfolio encompasses modified atmosphere packaging films for fresh and processed meats, poultry and cheese; specialty films for converting applications including printing, laminating and bag making; biaxially oriented nylon films for food, industrial and other uses; rigid containers such as portion control, single-serve, custom and retort trays for food, pet food, beverage, dairy, industrial and healthcare markets; flexible lidding in die-cut, daisy chain and rollstock formats for similar applications; specialized printed packaging for pharmaceutical, healthcare, nutraceutical, cosmetic and personal care sectors; and horizontal fill/seal machines for preformed containers plus vertical form/fill/seal pouch machines for pumpable liquids, semi-liquids and dry products. The company operates through three segments including flexible packaging, rigid packaging and flexible lidding, and packaging machinery; it serves food and beverage, dairy, protein, pet food and healthcare markets with production facilities across Canada, the United States and Mexico. Founded in 1975 and headquartered in Winnipeg, Manitoba, Canada, Winpak Ltd. functions as a subsidiary of Wihuri International Oy. In recent developments, the company completes a multi-year, over $100 million expansion of its Winnipeg modified atmosphere packaging facility in 2025 to boost capacity for recycle-ready products and projects sales volume growth of 5 to 7 percent amid focus on pet food, in-mold-label, dairy and healthcare markets; it secures SBTi approval for near-term science-based emissions reduction targets and publishes its 2025 Sustainability Report highlighting progress on GHG emissions, energy and waste goals; launches Medform DT, a next-generation forming film for healthcare packaging, and the Winspeed portfolio for pharmaceutical supply chain agility; raises its quarterly dividend to 5 Canadian cents per share from 3 cents and pays a $3.00 Canadian cents special dividend in January 2025; fulfills and renews normal course issuer bid programs repurchasing millions of shares; and forecasts 2025 capital expenditures of $80 to $90 million while evaluating acquisitions in medical and pharmaceutical applications.